Andson Biotech Inc.
Publicly observedAtlanta, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Atlanta | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Andson Biotech Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JN6BFBRSN5K7 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant3 Sept 2026Publicly observed
NIH SBIR/STTR award: Development of an Automated Sample Preparation Platform for High Throughput Mass Spectrometry Characterization of Biotherapeutics
USD 1,403,671.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant2 Aug 2025Publicly observed
NIH SBIR/STTR award: A Real-Time Mass Spectrometry Platform for In-Process Monitoring and Cell State Analysis
USD 302,671.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.